Literature DB >> 6110530

Benzodiazepines and drug abuse: clinical observations in chemically dependent persons before and during abstinence.

P Cushman, D Benzer.   

Abstract

Sixty-nine (9.2%) of 750 consecutive persons entering a chemical-dependence treatment hospital had urinary evidence of benzodiazepines, a somewhat higher proportion than in the general adult American population. The 54 subjects in whose urine benzodiazepines, but not the other commonly abused psychoactive drugs, were detected, had varied clinical findings. One had used benzodiazepines only, 38 others were alcoholic benzodiazepine users, and 15 were multiple-drug (including benzodiazepines) users. Of these 54 only 6 (11%) developed major withdrawal symptoms. All 6 had used high doses of benzodiazepines (larger than or equal to 30 mg of diazepam or equivalent) daily. The risk of major withdrawal symptoms was about 50% for the high benzodiazepines--heavy alcohol group and zero for all other benzodiazepine-consuming patients. While clinical vigilance regarding withdrawal is urged for all benzodiazepine consumers, it is especially important amongst alcoholics, consuming high doses of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110530     DOI: 10.1016/0376-8716(80)90019-8

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  3 in total

1.  Benzodiazepines are Prescribed More Frequently to Patients Already at Risk for Benzodiazepine-Related Adverse Events in Primary Care.

Authors:  David S Kroll; Harry Reyes Nieva; Arthur J Barsky; Jeffrey A Linder
Journal:  J Gen Intern Med       Date:  2016-05-13       Impact factor: 5.128

2.  Chlordiazepoxide effects on ethanol self-administration: dependence on concurrent conditions.

Authors:  H H Samson; K A Grant
Journal:  J Exp Anal Behav       Date:  1985-05       Impact factor: 2.468

Review 3.  Benzodiazepine high-doses: The need for an accurate definition.

Authors:  Jean-Marc Cloos; Christopher Y S Lim Cow; Valéry Bocquet
Journal:  Int J Methods Psychiatr Res       Date:  2021-07-31       Impact factor: 4.035

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.